作者
Julia Bohlius, Jayne Wilson, Jerome Seidenfeld, Margret Piper, Guido Schwarzer, Josie Sandercock, Sven Trelle, Olaf Weingart, Susan Bayliss, Susan Brunskill, Benjamin Djulbegovic, Charles Bennett, Simon Langensiepen, Chris Hyde, Andreas Engert
发表日期
2006
来源
Cochrane Database of Systematic Reviews
期号
3
出版商
John Wiley & Sons, Ltd
简介
Background
Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoietin (Epo), darbepoetin (Darbepo) and red blood cell transfusions.
Objectives
The aim of this systematic review was to assess the effects of Epo or Darbepo to either prevent or treat anaemia in cancer patients.
引用总数
学术搜索中的文章
J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer… - Cochrane Database of Systematic Reviews, 2006
J Bohlius, K Schmidlin, C Brillant, G Schwarzer… - Cochrane database of systematic reviews, 2009